---
stable_id: R-HSA-9737710
display_name: SARS-CoV-1 N binds SMAD3 and EP300 at the SERPINE1 gene promoter
species: Homo sapiens
summary: 'Severe acute respiratory syndrome associated coronavirus type 1 (SARS-CoV-1)
  nucleoprotein (N) is mostly cytoplasmic but can localize to the nucleus (Timani
  KA et al. 2005; You J et al. 2005). In the nucleus, SARS-CoV-1 N protein potentiates
  transforming growth factor-beta (TGF-β)-induced SMAD-mediated expression of plasminogen
  activator inhibitor-1 (PAI-1, encoded by the SERPINE1 gene) (Zhao X et al. 2008).
  Under normal conditions, the plasma level of SERPINE1 is relatively low. The expression
  of SERPINE1 is regulated by the activated SMAD complex (SMAD3:SMAD4) (Dennler S
  et al. 1998; Stroschein SL et al. 1999) that binds to the promoter of the SERPINE1
  gene together with the transcription factor SP1 (shown in mouse cells, Yuan H et
  al. 2013) and the histone acetyltransferase EP300 (p300) (Zhao X et al. 2008). <br>Upon
  SARS-CoV-1 infection, viral N associates with SMAD3 in human peripheral lung epithelial
  (HPL1) cells  (Zhao X et al. 2008). The N binding to SMAD3 enhanced SMAD3:EP300
  complex formation in human HEK293T cells. Chromatin immunoprecipitation (ChIP) assay
  showed the association of N and the SERPINE1 promoter in HPL1 cells that stably
  expressed N protein (Zhao X et al. 2008). The interaction between SARS-CoV-1 N and
  SMAD3 also prevented SMAD3 from complexing with SMAD4 (Zhao X et al. 2008).<p>Increased
  levels of active SERPINE1 may lead to coagulation dysfunctions which have been associated
  with an increased risk of ischemic cardiovascular events and tissue fibrosis (Ha
  H et al. 2009; ). '
---

# SARS-CoV-1 N binds SMAD3 and EP300 at the SERPINE1 gene promoter
**Reactome ID:** [R-HSA-9737710](https://reactome.org/content/detail/R-HSA-9737710)
**Species:** Homo sapiens

## Summary

Severe acute respiratory syndrome associated coronavirus type 1 (SARS-CoV-1) nucleoprotein (N) is mostly cytoplasmic but can localize to the nucleus (Timani KA et al. 2005; You J et al. 2005). In the nucleus, SARS-CoV-1 N protein potentiates transforming growth factor-beta (TGF-β)-induced SMAD-mediated expression of plasminogen activator inhibitor-1 (PAI-1, encoded by the SERPINE1 gene) (Zhao X et al. 2008). Under normal conditions, the plasma level of SERPINE1 is relatively low. The expression of SERPINE1 is regulated by the activated SMAD complex (SMAD3:SMAD4) (Dennler S et al. 1998; Stroschein SL et al. 1999) that binds to the promoter of the SERPINE1 gene together with the transcription factor SP1 (shown in mouse cells, Yuan H et al. 2013) and the histone acetyltransferase EP300 (p300) (Zhao X et al. 2008). <br>Upon SARS-CoV-1 infection, viral N associates with SMAD3 in human peripheral lung epithelial (HPL1) cells  (Zhao X et al. 2008). The N binding to SMAD3 enhanced SMAD3:EP300 complex formation in human HEK293T cells. Chromatin immunoprecipitation (ChIP) assay showed the association of N and the SERPINE1 promoter in HPL1 cells that stably expressed N protein (Zhao X et al. 2008). The interaction between SARS-CoV-1 N and SMAD3 also prevented SMAD3 from complexing with SMAD4 (Zhao X et al. 2008).<p>Increased levels of active SERPINE1 may lead to coagulation dysfunctions which have been associated with an increased risk of ischemic cardiovascular events and tissue fibrosis (Ha H et al. 2009; ). 
